Skip to content
Search

Latest Stories

Submit Guest Post

Minister Zahawi says he is confident to achieve UK's 'herculean' vaccine target

Minister Zahawi says he is confident to achieve UK's 'herculean' vaccine target

BRITISH prime minister Boris Johnson's 'herculean' aim to vaccinate around 14 million of the most vulnerable people against Covid-19 by the middle of next month is achievable, his vaccine minister said on Wednesday(6).

As major powers eye the benefits of being first out of the pandemic, Britain is rushing to vaccinate its population faster than the US and the rest of Europe, although Russia and China have been inoculating their citizens for months.


The vaccine is seen as the main way out of the Covid-19 crisis which has killed 1.87 million people, destroyed whole swathes of the global economy and upended normal life for billions of people across the world.

Johnson has set a target of vaccinating the elderly, including care home residents, the clinically vulnerable and frontline workers - around 14 million people - by mid-February.

Asked if it was achievable to vaccinate 14 million people by the middle of February and 2 million vaccinations each week by the end of this month, minister for Covid Vaccine Deployment Nadhim Zahawi said it was.

"It is a Herculean effort," he told Sky, adding that it was stretching but deliverable. He said that 1/4 of people over 80 years old had been vaccinated with their first shot.

More than 1.3 million people in the UK have been vaccinated against Covid-19.

Britain, grappling with the world's fifth worst death toll and one of the worst economic hits from the Covid crisis, was the first country to roll out the vaccine developed by Pfizer and Germany's BioNTech just under a month ago.

The UK this week became the first country in the world to start deploying the vaccine developed by AstraZeneca and Oxford University.

Add EasternEye As Your Trusted Source
preferred source on google news

More For You

PCOS

PCOS must be recognised as a chronic condition

iStock

Why PCOS poses a greater long-term health risk for South Asian women

Dr Kalpana Purshottamdas Lakhani

PCOS is often dismissed as a reproductive issue, but for south Asian women the consequences reach far beyond the ovary — affecting metabolic health, fertility, and lifelong wellbeing.

Polycystic ovary syndrome (PCOS) is one of the most common hormonal conditions in women, affecting an estimated 8–13% worldwide. But for south Asian women, the impact is even greater — and far less recognised. Research shows that south Asian women have higher insulin resistance, develop type 2 diabetes five to ten years earlier than white European women, and experience more severe metabolic features when they have PCOS. They also face higher rates of gestational diabetes and earlier cardiovascular risk. These differences make the long-term consequences of PCOS particularly significant in this community.

Keep ReadingShow less